{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:09:18Z","timestamp":1794668958780,"version":"4.9.1"},"reference-count":322,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["2U54MD017979-01A1"],"award-info":[{"award-number":["2U54MD017979-01A1"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00710","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T03:47:59Z","timestamp":1753415279000},"page":"e00710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide"],"prefix":"10.1016","volume":"22","author":[{"given":"Jennifer L.","family":"O'Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionisia M.","family":"Fountos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Firouzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/819cbf4a-7e3e-4e4e-a449-b667bc6e8957","article-title":"Correction: the neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis","volume":"6","author":"Panneton","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib2","first-page":"8","article-title":"The future burden of Parkinson's disease","volume":"33","author":"Rocca","year":"2017","journal-title":"Offic J Inter Parkinson Mov Dis Soc"},{"key":"10.1016\/j.neurot.2025.e00710_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy. 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2014.09.010","article-title":"Pathogenic mechanisms of neurodegeneration in Parkinson disease","volume":"33","author":"Mullin","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neurot.2025.e00710_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137961","article-title":"Tyrosine hydroxylase expression and neuronal loss in the male and female adolescent ventral tegmental area","volume":"841","author":"Riesgo","year":"2024","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/brainsci12060779","article-title":"Changes in tyrosine hydroxylase activity and dopamine synthesis in the nigrostriatal system of mice in an acute model of Parkinson's disease as a manifestation of neurodegeneration and neuroplasticity","volume":"12","author":"Kolacheva","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.neurot.2025.e00710_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9730467","article-title":"The role of dopamine and its dysfunction as a consequence of oxidative stress","volume":"2016","author":"Ju\u00e1rez Olgu\u00edn","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib9","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1038\/npp.2014.129","article-title":"Control of the nigrostriatal dopamine neuron activity and motor function by the tail of the ventral tegmental area","volume":"39","author":"Bourdy","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00710_bib10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: implications in Parkinson's disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.neurot.2025.e00710_bib11","article-title":"Alpha-synuclein in Parkinson's disease","volume":"2016","author":"Xu","year":"2016"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017698","article-title":"Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein","volume":"6","author":"Koprich","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib14","article-title":"Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration","volume":"4","author":"Skorvanek","year":"2017","journal-title":"Offic J Inter Parkinson Movement Disorder Soc"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2025.e00710_bib17","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson's disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.neurot.2025.e00710_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2025.e00710_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Suppl","key":"10.1016\/j.neurot.2025.e00710_bib22","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.parkreldis.2007.06.007","article-title":"The premotor phase of Parkinson's disease","volume":"13","author":"Tolosa","year":"2007","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.neurot.2025.e00710_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177733","article-title":"NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease","volume":"1002","author":"Firouzan","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson's disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"issue":"4-6","key":"10.1016\/j.neurot.2025.e00710_bib25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-006-9061-9","article-title":"Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines","volume":"26","author":"Nagatsu","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00710_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fneur.2013.00033","article-title":"Molecular events underlying Parkinson's disease - an interwoven tapestry","volume":"4","author":"Lim","year":"2013","journal-title":"Front Neurol"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00710_bib27","article-title":"Determinants of dopaminergic neuron loss in Parkinson's disease","volume":"285","author":"Dj","year":"2018","journal-title":"FEBS"},{"key":"10.1016\/j.neurot.2025.e00710_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson's disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front Neuroanat"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1159\/000430271","article-title":"Allicin protects PC12 cells against 6-OHDA-induced oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics","volume":"36","author":"Liu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.neurot.2025.e00710_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101665","article-title":"Teaching the basics of repurposing mitochondria-targeted drugs: from Parkinson's disease to cancer and back to Parkinson's disease","volume":"36","author":"Kalyanaraman","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00710_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fphys.2017.00691","article-title":"Gaseous mediators and mitochondrial function: the future of pharmacologically induced suspended animation?","volume":"8","author":"Hartmann","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.neurot.2025.e00710_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.02.030","article-title":"The role of hydrogen sulfide in health and disease","volume":"149","author":"Kashfi","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12031-014-0284-9","article-title":"Hydrogen sulfide protects the brain against ischemic reperfusion injury in a transient model of focal cerebral ischemia","volume":"54","author":"Gheibi","year":"2014","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neurot.2025.e00710_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2018.01.017","article-title":"Regulation of vascular tone homeostasis by NO and H(2)S: implications in hypertension","volume":"149","author":"Gheibi","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/18756190MTA2pMjApy","article-title":"Role of nitric oxide in neurodegeneration: function, regulation, and inhibition","volume":"19","author":"Tewari","year":"2021","journal-title":"Curr Neuropharmacol"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00710_bib37","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2174\/1381612811319150013","article-title":"Carbon Monoxide and the brain: time to rethink the dogma","volume":"19","author":"Hanafy","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neurot.2025.e00710_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115230","article-title":"Carbon monoxide and its role in human physiology: a brief historical perspective","volume":"204","author":"Kashfi","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00710_bib39","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1096\/fj.04-1815fje","article-title":"Hydrogen sulfide protects neurons from oxidative stress","volume":"18","author":"Kimura","year":"2004","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2006.04283.x","article-title":"Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia","volume":"100","author":"Hu","year":"2007","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/glia.20905","article-title":"Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation","volume":"58","author":"Lee","year":"2010","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017225118","article-title":"Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3\u03b2 and inhibiting Tau hyperphosphorylation","volume":"118","author":"Giovinazzo","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2025.e00710_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40035-018-0108-x","article-title":"Hydrogen sulfide, nitric oxide, and neurodegenerative disorders","volume":"7","author":"Panthi","year":"2018","journal-title":"Transl Neurodegener"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/ars.2010.3671","article-title":"Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease","volume":"15","author":"Kida","year":"2011","journal-title":"Antioxidants Redox Signal"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1474-9726.2009.00543.x","article-title":"Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models","volume":"9","author":"Hu","year":"2010","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060200","article-title":"Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib47","first-page":"964","article-title":"Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease","volume":"17","author":"Kouti","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib48","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1161\/hh0202.104530","article-title":"Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities","volume":"90","author":"Motterlini","year":"2002","journal-title":"Circ Res"},{"issue":"Pt 5","key":"10.1016\/j.neurot.2025.e00710_bib49","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1042\/BST0351142","article-title":"Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities","volume":"35","author":"Motterlini","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.neurot.2025.e00710_bib50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2014.10.017","article-title":"The role of the nitric oxide pathway in brain injury and its treatment--from bench to bedside","volume":"263","author":"Garry","year":"2015","journal-title":"Exp Neurol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00710_bib51","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/glia.22553","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders","volume":"61","author":"Lee","year":"2013","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00710_bib52","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/STROKEAHA.110.607101","article-title":"Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia","volume":"42","author":"Wang","year":"2011","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41531-024-00763-6","article-title":"Neuroprotection of low dose carbon monoxide in Parkinson's disease models commensurate with the reduced risk of Parkinson's among smokers","volume":"10","author":"Rose","year":"2024","journal-title":"npj Parkinson's Dis"},{"issue":"10291","key":"10.1016\/j.neurot.2025.e00710_bib54","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biology8020038","article-title":"Mitochondrial dysfunction in Parkinson's disease-cause or consequence?","volume":"8","author":"Chen","year":"2019","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"6357","key":"10.1016\/j.neurot.2025.e00710_bib57","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP","volume":"186","author":"Song","year":"2004","journal-title":"Exp Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.neurot.2025.e00710_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bjd.12208","article-title":"The role of mitochondrial function and cellular bioenergetics in ageing and disease","volume":"169","author":"Brand","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","article-title":"Cellular and molecular mechanisms of mitochondrial function","volume":"26","author":"Osellame","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"8649","key":"10.1016\/j.neurot.2025.e00710_bib62","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib63","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.410360612","article-title":"Complex I, iron, and ferritin in Parkinson's disease substantia nigra","volume":"36","author":"Mann","year":"1994","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.410400417","article-title":"Origin and functional consequences of the complex I defect in Parkinson's disease","volume":"40","author":"Swerdlow","year":"1996","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00710_bib65","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13024-024-00756-2","article-title":"\u03b1-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease","volume":"19","author":"Geibl","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib67","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1523\/ENEURO.0544-20.2021","article-title":"Snca-GFP knock-in mice allows tracking the endogenous \u03b1-synuclein in action","volume":"8","author":"Er","year":"2021","journal-title":"Eneuro"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00710_bib68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dmm.026294","article-title":"Mitochondrial dynamics in Parkinson's disease: a role for \u03b1-synuclein?","volume":"10","author":"Pozo","year":"2017","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00710_bib70","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.1073\/pnas.1216197110","article-title":"Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan","volume":"110","author":"Rana","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2025.e00710_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2019.07.001","article-title":"Gasotransmitters in health and disease: a mitochondria-centered view","volume":"45","author":"Hendriks","year":"2019","journal-title":"Curr Opin Pharmacol"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00710_bib72","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1073\/pnas.95.13.7631","article-title":"Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione","volume":"95","author":"Clementi","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3-4","key":"10.1016\/j.neurot.2025.e00710_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0891-0618(98)00032-5","article-title":"Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity","volume":"14","author":"Mohanakumar","year":"1998","journal-title":"J Chem Neuroanat"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib74","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-2396(199605)23:1<58::AID-SYN7>3.0.CO;2-G","article-title":"S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo","volume":"23","author":"Rauhala","year":"1996","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.52586\/S556","article-title":"Mitochondrial mechanisms by which gasotransmitters (H(2)S, NO and CO) protect cardiovascular system against hypoxia","volume":"13","author":"Shemarova","year":"2021","journal-title":"Front Biosci"},{"issue":"39","key":"10.1016\/j.neurot.2025.e00710_bib76","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","article-title":"Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function","volume":"104","author":"Elrod","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2025.e00710_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/749845","article-title":"Carbon monoxide targeting mitochondria","volume":"2012","author":"Queiroga","year":"2012","journal-title":"Biochem Res Int"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib78","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13054-015-0903-z","article-title":"Effects of inhalation of low-dose nitrite or carbon monoxide on post-reperfusion mitochondrial function and tissue injury in hemorrhagic shock swine","volume":"19","author":"Haugaa","year":"2015","journal-title":"Crit Care"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00710_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215402","article-title":"Animal models for Parkinson's disease research: trends in the 2000s","volume":"20","author":"Kin","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib80","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ane.12563","article-title":"The genetic background of Parkinson's disease: current progress and future prospects","volume":"134","author":"Kalinderi","year":"2016","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib81","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neurot.2025.e00710_bib82","first-page":"49","article-title":"MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects","volume":"100","author":"Langston","year":"1984","journal-title":"Acta Neurol Scand Suppl"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib83","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib84","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00710_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)01255-9","article-title":"MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport","volume":"715","author":"Desai","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00710_bib86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","article-title":"The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future","volume":"184","author":"Fox","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neurot.2025.e00710_bib87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","article-title":"Neurotoxin-based models of Parkinson's disease","volume":"211","author":"Bov\u00e9","year":"2012","journal-title":"Neuroscience"},{"issue":"3-4","key":"10.1016\/j.neurot.2025.e00710_bib88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neurot.2025.e00710_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114585","article-title":"Dipeptide mimetic of BDNF ameliorates motor dysfunction and striatal apoptosis in 6-OHDA-induced Parkinson's rat model: considering Akt and MAPKs signaling","volume":"452","author":"Firouzan","year":"2023","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib90","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neurot.2025.e00710_bib91","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front Behav Neurosci"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib92","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00710_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib94","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/toxsci\/kfr058","article-title":"Maneb and paraquat-mediated neurotoxicity: involvement of peroxiredoxin\/thioredoxin system","volume":"121","author":"Roede","year":"2011","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib95","first-page":"945","article-title":"Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase C\u03b4 in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration","volume":"119","author":"Kitazawa","year":"2003"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib96","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"issue":"51","key":"10.1016\/j.neurot.2025.e00710_bib97","doi-asserted-by":"crossref","first-page":"20766","DOI":"10.1073\/pnas.1115141108","article-title":"Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3","volume":"108","author":"Rappold","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib98","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of Parkinson's disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS J"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib99","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","article-title":"What genetics tells us about the causes and mechanisms of Parkinson's disease","volume":"91","author":"Corti","year":"2011","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib101","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2012.06.003","article-title":"Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease","volume":"98","author":"Wang","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00710_bib102","first-page":"67","article-title":"Genetic basis of Parkinson's disease: inheritance, penetrance, and expression","volume":"4","author":"Schulte","year":"2011","journal-title":"Appl Clin Genet"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib103","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14737175.7.6.657","article-title":"Genetics of Parkinson's disease and parkinsonism","volume":"7","author":"Douglas","year":"2007","journal-title":"Expert Rev Neurother"},{"issue":"5646","key":"10.1016\/j.neurot.2025.e00710_bib104","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"Suppl 2","key":"10.1016\/j.neurot.2025.e00710_bib105","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.parkreldis.2008.04.004","article-title":"Strengths and limitations of genetic mouse models of Parkinson's disease","volume":"14","author":"Chesselet","year":"2008","journal-title":"Parkinsonism Relat Disorders"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib106","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2007.08.006","article-title":"In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?","volume":"209","author":"Chesselet","year":"2008","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib108","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib109","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib111","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00710_bib113","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00710_bib114","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","article-title":"Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse","volume":"12","author":"Itier","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/NEN.0000000000000039","article-title":"Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegeneration","volume":"73","author":"Van Rompuy","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurot.2025.e00710_bib116","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.niox.2017.08.003","article-title":"Anti-obesity and anti-diabetic effects of nitrate and nitrite","volume":"70","author":"Ghasemi","year":"2017","journal-title":"Nitric Oxide"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib117","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/pr.120.019240","article-title":"The noncanonical pathway for in vivo nitric oxide generation: the nitrate-nitrite-nitric oxide pathway","volume":"72","author":"Kapil","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurot.2025.e00710_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1480838","article-title":"The potential role of nitrate, a nitric oxide donor, in the prevention and treatment of diabetic osteoporosis","volume":"16","author":"Jeddi","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.neurot.2025.e00710_bib119","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2018.01.017","article-title":"Regulation of vascular tone homeostasis by NO and H2S: implications in hypertension","volume":"149","author":"Gheibi","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-0173(00)00051-5","article-title":"Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type","volume":"35","author":"Law","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib121","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0006-8993(02)03261-4","article-title":"Immunohistochemical study on the distribution of nitrotyrosine and neuronal nitric oxide synthase in aged rat cerebellum","volume":"951","author":"Chung","year":"2002","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib122","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0006-8993(02)03261-4","article-title":"Immunohistochemical study on the distribution of nitrotyrosine and neuronal nitric oxide synthase in aged rat cerebellum","volume":"951","author":"Chung","year":"2002","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib123","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1750-3639.2007.00104.x","article-title":"Vascular endothelial growth factor and nitric oxide production in response to hypoxia in the choroid plexus in neonatal brain","volume":"18","author":"Sivakumar","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neurot.2025.e00710_bib124","series-title":"Role of nitric oxide synthase in the function of the central nervous system under normal and infectious conditions","year":"2017"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib125","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.neurot.2025.e00710_bib126","first-page":"1","article-title":"Enzymology of nitric oxide synthases","volume":"100","author":"Hemmens","year":"1998","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neurot.2025.e00710_bib127","first-page":"470","article-title":"Quantitative aspects of nitric oxide production from nitrate and nitrite","volume":"21","author":"Ghasemi","year":"2022","journal-title":"Excli J"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nchembio.92","article-title":"A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis","volume":"4","author":"Jansson","year":"2008","journal-title":"Nat Chem Biol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib129","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.bcp.2008.12.006","article-title":"Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation","volume":"77","author":"Cordes","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00710_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1681.2006.04316.x","article-title":"Amino acids, arginase and nitric oxide in vascular health","volume":"33","author":"Huynh","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib132","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/joim.12441","article-title":"Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases","volume":"279","author":"Omar","year":"2016","journal-title":"J Intern Med"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00710_bib133","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","article-title":"Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation","volume":"109","author":"Coletta","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2025.e00710_bib134","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1749-6632.1995.tb17477.x","article-title":"S-nitrosylation of m2 muscarinic receptor thiols disrupts receptor-G-protein coupling","volume":"757","author":"Aronstam","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00710_bib135","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib136","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10863-008-9166-6","article-title":"The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance","volume":"40","author":"Cooper","year":"2008","journal-title":"J Bioenerg Biomembr"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib137","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35055104","article-title":"Protein S-nitrosylation: a physiological signal for neuronal nitric oxide","volume":"3","author":"Jaffrey","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib138","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1152\/jappl.2001.91.3.1421","article-title":"Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression","volume":"91","author":"Lincoln","year":"2001","journal-title":"J Appl Physiol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00710_bib139","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.neurot.2025.e00710_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121129","article-title":"Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson's disease model","volume":"310","author":"Sayed","year":"2022","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020389","article-title":"Vanillin protects dopaminergic neurons against inflammation-mediated cell death by inhibiting ERK1\/2, P38 and the NF-\u03baB signaling pathway","volume":"18","author":"Yan","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00710_bib142","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1742-2094-8-121","article-title":"Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1\/2, iNOS and sPLA2-IIA expression in astrocytes and microglia","volume":"8","author":"Sheng","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib143","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tplants.2005.02.008","article-title":"New insights into nitric oxide metabolism and regulatory functions","volume":"10","author":"Crawford","year":"2005","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.neurot.2025.e00710_bib144","series-title":"Cell signalling biology","author":"Berridge","year":"2014"},{"key":"10.1016\/j.neurot.2025.e00710_bib145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2014.05.016","article-title":"Regulation of obesity and insulin resistance by nitric oxide","volume":"73","author":"Sansbury","year":"2014","journal-title":"Free Radical Biol Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib146","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib147","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/71090","article-title":"Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation","volume":"3","author":"Choi","year":"2000","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib148","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-2236(00)01745-8","article-title":"Nitric oxide: a novel link between synaptic and nonsynaptic transmission","volume":"24","author":"Kiss","year":"2001","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib149","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1073\/pnas.97.4.1845","article-title":"Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission","volume":"97","author":"Pieper","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib150","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.1993.tb13732.x","article-title":"Alpha 2-adrenoceptor-mediated modulation of the nitrergic innervation of the canine isolated ileocolonic junction","volume":"109","author":"Boeckxstaens","year":"1993","journal-title":"Br J Pharmacol"},{"issue":"6455","key":"10.1016\/j.neurot.2025.e00710_bib151","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/366562a0","article-title":"Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide","volume":"366","author":"Hess","year":"1993","journal-title":"Nature"},{"issue":"6526","key":"10.1016\/j.neurot.2025.e00710_bib152","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/375068a0","article-title":"Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells","volume":"375","author":"Peunova","year":"1995","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00710_bib153","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.94.20.10925","article-title":"Reduced stress defense in heme oxygenase 1-deficient cells","volume":"94","author":"Poss","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib154","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0891-5849(99)00223-3","article-title":"The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties","volume":"28","author":"Ryter","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurot.2025.e00710_bib155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pneurobio.2018.06.008","article-title":"The sinister face of heme oxygenase-1 in brain aging and disease","volume":"172","author":"Schipper","year":"2019","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00710_bib156","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.pharmtox.37.1.517","article-title":"The heme oxygenase system: a regulator of second messenger gases","volume":"37","author":"Maines","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4-5","key":"10.1016\/j.neurot.2025.e00710_bib157","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000094160","article-title":"Heme oxygenase 1 in cerebrospinal fluid from infants and children after severe traumatic brain injury","volume":"28","author":"Cousar","year":"2006","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neurot.2025.e00710_bib158","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1306.007","article-title":"Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress","volume":"1012","author":"Schipper","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib159","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.freeradbiomed.2004.09.015","article-title":"Heme oxygenase expression in human central nervous system disorders","volume":"37","author":"Schipper","year":"2004","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.neures.2009.08.007","article-title":"Cerebral heme oxygenase 1 and 2 spatial distribution is modulated following injury from hypoxia-ischemia and middle cerebral artery occlusion in rats","volume":"65","author":"Sutherland","year":"2009","journal-title":"Neurosci Res"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib161","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1073\/pnas.92.5.1475","article-title":"Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP","volume":"92","author":"Morita","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib162","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCRESAHA.108.172148","article-title":"Protein carbonylation and decarboylation: a new twist to the complex response of vascular cells to oxidative stress","volume":"102","author":"Cattaruzza","year":"2008","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00710_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116029","article-title":"Carbon monoxide and nitric oxide as examples of the youngest class of transmitters","volume":"22","author":"Nowaczyk","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"41","key":"10.1016\/j.neurot.2025.e00710_bib164","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1039\/b704873d","article-title":"CO and NO in medicine","author":"Mann","year":"2007","journal-title":"Chem Commun"},{"key":"10.1016\/j.neurot.2025.e00710_bib165","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.freeradbiomed.2013.09.005","article-title":"Mechanism of protein decarbonylation","volume":"65","author":"Wong","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00710_bib166","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.tibs.2006.09.001","article-title":"CO-metal interaction: vital signaling from a lethal gas","volume":"31","author":"Boczkowski","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neurot.2025.e00710_bib167","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jss.2018.03.042","article-title":"Carbon monoxide attenuates lipopolysaccharide-induced lung injury by mitofusin proteins via p38 MAPK pathway","volume":"228","author":"Dong","year":"2018","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib168","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/tox.22514","article-title":"Andrographolide inhibits hypoxia-induced hypoxia-inducible factor 1\u03b1 and endothelin 1 expression through the heme oxygenase 1\/CO\/cGMP\/MKP-5 pathways in EA.hy926 cells","volume":"33","author":"Lin","year":"2018","journal-title":"Environ Toxicol"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00710_bib169","doi-asserted-by":"crossref","first-page":"23919","DOI":"10.18632\/oncotarget.8081","article-title":"Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth","volume":"7","author":"Nemeth","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib170","doi-asserted-by":"crossref","first-page":"C211","DOI":"10.1152\/ajpcell.00022.2017","article-title":"Carbon monoxide in lung cell physiology and disease","volume":"314","author":"Ryter","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib171","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2025.e00710_bib172","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fendo.2013.00087","article-title":"Production of hydrogen sulfide from d-cysteine and its therapeutic potential","volume":"4","author":"Shibuya","year":"2013","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib173","doi-asserted-by":"crossref","first-page":"C537","DOI":"10.1152\/ajpcell.00329.2016","article-title":"Vascular biology of hydrogen sulfide","volume":"312","author":"Kanagy","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib174","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00726-004-0072-x","article-title":"Endogenous production of hydrogen sulfide in mammals","volume":"26","author":"Kamoun","year":"2004","journal-title":"Amino Acids"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib175","first-page":"187","article-title":"Purification and characterization of cysteine aminotransferase from rat liver cytosol","volume":"36","author":"Akagi","year":"1982","journal-title":"Acta Med Okayama"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib176","first-page":"483","article-title":"Purification and characterization of mitochondrial cysteine aminotransferase from rat liver","volume":"10","author":"Ubuka","year":"1978","journal-title":"Physiol Chem Phys"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00710_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12081644","article-title":"Regulation of mitochondrial respiration by hydrogen sulfide","volume":"12","author":"Huang","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/biom14010129","article-title":"Hydrogen sulfide (H(2)S)\/Polysulfides (H(2)S(n)) signalling and TRPA1 channels modification on sulfur metabolism","volume":"14","author":"Kimura","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.neurot.2025.e00710_bib179","series-title":"Chemistry, biochemistry and pharmacology of hydrogen sulfide","author":"Moore","year":"2015"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib180","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1096\/fj.12-216507","article-title":"Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics","volume":"27","author":"M\u00f3dis","year":"2013","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib181","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib182","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/ars.2008.2253","article-title":"3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2009","journal-title":"Antioxidants Redox Signal"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067322","article-title":"Brain 3-mercaptopyruvate sulfurtransferase (3MST): cellular localization and downregulation after acute stroke","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib184","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.freeradbiomed.2006.03.021","article-title":"Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide","volume":"41","author":"Oh","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00710_bib185","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1096\/fj.05-3724fje","article-title":"Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia\/astrocyte lineage of developing mouse CNS","volume":"19","author":"Enokido","year":"2005","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib186","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.bbrc.2005.10.118","article-title":"Cystathionine beta-synthase is enriched in the brains of Down's patients","volume":"338","author":"Ichinohe","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib187","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4196\/kjpp.2009.13.3.195","article-title":"Zinc inhibits amyloid beta production from alzheimer's amyloid precursor protein in SH-SY5Y cells","volume":"13","author":"Lee","year":"2009","journal-title":"Korean J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib188","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ab.2005.03.024","article-title":"Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues","volume":"341","author":"Doeller","year":"2005","journal-title":"Anal Biochem"},{"issue":"5-6","key":"10.1016\/j.neurot.2025.e00710_bib189","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/ars.2005.7.795","article-title":"Physiological roles of hydrogen sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation","volume":"7","author":"Kimura","year":"2005","journal-title":"Antioxidants Redox Signal"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/ecp.10.134","article-title":"Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising","volume":"4","author":"Whiteman","year":"2011","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"96","key":"10.1016\/j.neurot.2025.e00710_bib191","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000464","article-title":"H2S signals through protein S-sulfhydration","volume":"2","author":"Mustafa","year":"2009","journal-title":"Sci Signal"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib192","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","article-title":"Hydrogen sulfide mediates cardioprotection through Nrf2 signaling","volume":"105","author":"Calvert","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.neurot.2025.e00710_bib193","article-title":"The role of the signaling pathways involved in the effects of hydrogen sulfide on endoplasmic reticulum stress","volume":"9","author":"Zhao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.neurot.2025.e00710_bib194","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.042","article-title":"The dichotomous role of H(2)S in cancer cell biology? D\u00e9j\u00e0 vu all over again","volume":"149","author":"Kashfi","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00710_bib195","doi-asserted-by":"crossref","first-page":"31888","DOI":"10.18632\/oncotarget.16649","article-title":"Sulfhydration-associated phosphodiesterase 5A dimerization mediates vasorelaxant effect of hydrogen sulfide","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neurot.2025.e00710_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.674135","article-title":"The role of protein persulfidation in brain aging and neurodegeneration","volume":"13","author":"Petrovic","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib197","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/pr.55.2.3","article-title":"The pharmacology of nitric oxide in the peripheral nervous system of blood vessels","volume":"55","author":"Toda","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib198","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat Med"},{"issue":"5 Pt 1","key":"10.1016\/j.neurot.2025.e00710_bib199","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","article-title":"Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly","volume":"271","author":"Beckman","year":"1996","journal-title":"Am J Physiol"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00710_bib200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pharmthera.2005.05.007","article-title":"Role of nitric oxide in Parkinson's disease","volume":"109","author":"Zhang","year":"2006","journal-title":"Pharmacol Therapeut"},{"issue":"37","key":"10.1016\/j.neurot.2025.e00710_bib201","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.R113.472936","article-title":"Peroxynitrite, a stealthy biological oxidant","volume":"288","author":"Radi","year":"2013","journal-title":"J Biol Chem"},{"issue":"5-6","key":"10.1016\/j.neurot.2025.e00710_bib202","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1089\/ars.2005.7.672","article-title":"Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders","volume":"7","author":"Norris","year":"2005","journal-title":"Antioxidants Redox Signal"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib203","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","article-title":"Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies","volume":"157","author":"Duda","year":"2000","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"5093","key":"10.1016\/j.neurot.2025.e00710_bib205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7678352","article-title":"Carbon monoxide: a putative neural messenger","volume":"259","author":"Verma","year":"1993","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib206","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/bph.12729","article-title":"Carbon monoxide and the CNS: challenges and achievements","volume":"172","author":"Queiroga","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib207","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1152\/physrev.00011.2005","article-title":"Heme oxygenase-1\/carbon monoxide: from basic science to therapeutic applications","volume":"86","author":"Ryter","year":"2006","journal-title":"Physiol Rev"},{"issue":"42","key":"10.1016\/j.neurot.2025.e00710_bib208","doi-asserted-by":"crossref","first-page":"32116","DOI":"10.1074\/jbc.M110.131284","article-title":"Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein","volume":"285","author":"Choi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00710_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00165","article-title":"Simvastatin inhibits activation of NADPH oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in Parkinson disease models","volume":"11","author":"Tong","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib210","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.107.097006","article-title":"Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II\u2013induced cardiac hypertrophy","volume":"50","author":"Kobayashi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.neurot.2025.e00710_bib211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2017.02.005","article-title":"Protective effect of Nrf2\u2013ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model","volume":"798","author":"Masaki","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib212","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuropharm.2009.11.003","article-title":"The mechanism of heme oxygenase-1 action involved in the enhancement of neurotrophic factor expression","volume":"58","author":"Hung","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2025.e00710_bib213","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fnmol.2017.00387","article-title":"Heme oxygenase-1 induction by carbon monoxide releasing molecule-3 suppresses interleukin-1\u03b2-mediated neuroinflammation","volume":"10","author":"Lin","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib214","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191207","article-title":"Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells","volume":"13","author":"Dreyer-Andersen","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41420-025-02530-9","article-title":"CO confers neuroprotection via activating the PERK-calcineurin pathway and inhibiting necroptosis","volume":"11","author":"Park","year":"2025","journal-title":"Cell Death Discov"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00710_bib216","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000869","article-title":"Increased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort study","volume":"94","author":"Lai","year":"2015","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib217","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5847\/wjem.j.issn.1920-8642.2014.02.002","article-title":"An assessment of antioxidant status in patients with carbon monoxide poisoning","volume":"5","author":"Zengin","year":"2014","journal-title":"World journal of emergency medicine"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib218","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1474-9726.2009.00543.x","article-title":"Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models","volume":"9","author":"Hu","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.neurot.2025.e00710_bib219","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/mol.108.047985","article-title":"Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function","volume":"75","author":"Hu","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib220","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.freeradbiomed.2008.09.014","article-title":"Hydrogen sulfide protects astrocytes against H2O2-induced neural injury via enhancing glutamate uptake","volume":"45","author":"Lu","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00710_bib221","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10863-014-9578-4","article-title":"The metabolic response to excitotoxicity - lessons from single-cell imaging","volume":"47","author":"Connolly","year":"2015","journal-title":"J Bioenerg Biomembr"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib222","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2004-6210","article-title":"Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy?","volume":"6","author":"Facheris","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurot.2025.e00710_bib223","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47372","article-title":"A circuit-dependent ROS feedback loop mediates glutamate excitotoxicity to sculpt the Drosophila motor system","volume":"8","author":"Peng","year":"2019","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib224","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib225","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3233\/JPD-223290","article-title":"Role of NLRP3 inflammasome in Parkinson's disease and therapeutic considerations","volume":"12","author":"Nguyen","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00710_bib226","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3109\/00207454.2014.982795","article-title":"Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair","volume":"125","author":"Vivekanantham","year":"2015","journal-title":"Int J Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib227","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1381612822666151125000300","article-title":"Inflammatory process in Alzheimer's and Parkinson's diseases: central role of cytokines","volume":"22","author":"Alam","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neurot.2025.e00710_bib228","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13587","article-title":"Hydrogen sulphide attenuates neuronal apoptosis of substantia nigra by re-establishing autophagic flux via promoting leptin signalling in a 6-hydroxydopamine rat model of Parkinson's disease","volume":"49","author":"Jiang","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.neurot.2025.e00710_bib229","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jconrel.2024.11.069","article-title":"Delivery of small interfering RNA by hydrogen sulfide-releasing nanomotor for the treatment of Parkinson's disease","volume":"377","author":"Wan","year":"2025","journal-title":"J Contr Release"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12967-017-1206-8","article-title":"Anti-inflammatory effects of H 2 S during acute bacterial infection: a review","volume":"15","author":"Benedetti","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.neurot.2025.e00710_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101772","article-title":"Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics","volume":"38","author":"Paul","year":"2021","journal-title":"Redox Biol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib232","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1139\/y88-063","article-title":"Effects of 6-hydroxydopamine on oxidative phosphorylation of mitochondria from rat striatum, cortex, and liver","volume":"66","author":"Thakar","year":"1988","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib233","doi-asserted-by":"crossref","first-page":"R669","DOI":"10.1152\/ajpregu.00807.2007","article-title":"Hydrogen sulfide as an oxygen sensor in trout gill chemoreceptors","volume":"295","author":"Olson","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00710_bib234","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1073\/pnas.1115634109","article-title":"Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production","volume":"109","author":"Fu","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00710_bib235","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.neuint.2013.09.021","article-title":"Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA","volume":"63","author":"Lorenc-Koci","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neurot.2025.e00710_bib236","first-page":"e42","article-title":"Nitric oxide signaling and neural stem cell differentiation in peripheral nerve regeneration","volume":"10","author":"Tao Li","year":"2010","journal-title":"Eplasty"},{"key":"10.1016\/j.neurot.2025.e00710_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108502","article-title":"The Triple Crown: NO, CO, and H(2)S in cancer cell biology","volume":"249","author":"Oza","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"68","key":"10.1016\/j.neurot.2025.e00710_bib238","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.268re2","article-title":"Signaling by gasotransmitters","volume":"2","author":"Mustafa","year":"2009","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib239","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00726-010-0510-x","article-title":"Hydrogen sulfide: its production, release and functions","volume":"41","author":"Kimura","year":"2011","journal-title":"Amino Acids"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00710_bib240","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","article-title":"Hydrogen sulphide and its therapeutic potential","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"32","key":"10.1016\/j.neurot.2025.e00710_bib241","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.2174\/0929867321666140706142930","article-title":"Hydrogen sulfide and endothelial dysfunction: relationship with nitric oxide","volume":"21","author":"Altaany","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neurot.2025.e00710_bib242","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphys.2011.00104","article-title":"Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism","volume":"2","author":"Predmore","year":"2011","journal-title":"Front Physiol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00710_bib243","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.freeradbiomed.2011.03.010","article-title":"Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency","volume":"50","author":"Crabtree","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib244","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1074\/jbc.M113.507533","article-title":"NO\u2217 binds human cystathionine \u03b2-synthase quickly and tightly","volume":"289","author":"Vicente","year":"2014","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00710_bib245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tips.2015.05.007","article-title":"The role of H2S bioavailability in endothelial dysfunction","volume":"36","author":"Wang","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2025.e00710_bib246","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.niox.2014.12.009","article-title":"On the chemical biology of the nitrite\/sulfide interaction","volume":"46","author":"Cortese-Krott","year":"2015","journal-title":"Nitric Oxide"},{"issue":"34","key":"10.1016\/j.neurot.2025.e00710_bib247","doi-asserted-by":"crossref","first-page":"E4651","DOI":"10.1073\/pnas.1509277112","article-title":"Key bioactive reaction products of the NO\/H2S interaction are S\/N-hybrid species, polysulfides, and nitroxyl","volume":"112","author":"Cortese-Krott","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib248","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/BJ20111389","article-title":"Biochemical insight into physiological effects of H(2)S: reaction with peroxynitrite and formation of a new nitric oxide donor, sulfinyl nitrite","volume":"441","author":"Filipovic","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.neurot.2025.e00710_bib249","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"5675","key":"10.1016\/j.neurot.2025.e00710_bib250","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.1093891","article-title":"S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function","volume":"304","author":"Chung","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurot.2025.e00710_bib251","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/ncomms2623","article-title":"Sulfhydration mediates neuroprotective actions of parkin","volume":"4","author":"Vandiver","year":"2013","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib252","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.cmet.2019.10.007","article-title":"Selective persulfide detection reveals Evolutionarily conserved antiaging effects of S-sulfhydration","volume":"30","author":"Zivanovic","year":"2019","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib253","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/acs.chemrev.7b00205","article-title":"Chemical biology of H(2)S signaling through persulfidation","volume":"118","author":"Filipovic","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.neurot.2025.e00710_bib254","doi-asserted-by":"crossref","DOI":"10.1038\/srep45995","article-title":"Polysulfides (H(2)S(n)) produced from the interaction of hydrogen sulfide (H(2)S) and nitric oxide (NO) activate TRPA1 channels","volume":"7","author":"Miyamoto","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00710_bib255","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1089\/ars.2020.8049","article-title":"Nitrosopersulfide (SSNO(-)) is a unique cysteine polysulfidating agent with reduction-resistant bioactivity","volume":"33","author":"Bogd\u00e1ndi","year":"2020","journal-title":"Antioxidants Redox Signal"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00710_bib256","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00710_bib257","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1021\/bi00184a036","article-title":"Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states","volume":"33","author":"Stone","year":"1994","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib258","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cardiores.2007.03.004","article-title":"Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2\/ARE complex to promote vascular smooth muscle cell survival","volume":"75","author":"Liu","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"43","key":"10.1016\/j.neurot.2025.e00710_bib259","doi-asserted-by":"crossref","first-page":"40666","DOI":"10.1074\/jbc.M203863200","article-title":"Induction of heme oxygenase 1 by nitrosative stress. A role for nitroxyl anion","volume":"277","author":"Naughton","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib260","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/15230860260220111","article-title":"Regulation of heme oxygenase-1 by redox signals involving nitric oxide","volume":"4","author":"Motterlini","year":"2002","journal-title":"Antioxidants Redox Signal"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib261","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/01.RES.80.4.557","article-title":"Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells","volume":"80","author":"Durante","year":"1997","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00710_bib262","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2174\/0929867033457746","article-title":"The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha)","volume":"10","author":"Br\u00fcne","year":"2003","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib263","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nm0302-240","article-title":"Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice","volume":"8","author":"Lee","year":"2002","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00710_bib264","doi-asserted-by":"crossref","first-page":"19325","DOI":"10.1074\/jbc.M300498200","article-title":"Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2","volume":"278","author":"Lee","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib265","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/74680","article-title":"Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway","volume":"6","author":"Otterbein","year":"2000","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib266","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1074\/jbc.M110.168831","article-title":"Heme oxygenase-1\/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1","volume":"286","author":"Lin","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib267","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.npp.1300132","article-title":"Effect of carbon monoxide on dopamine and glutamate uptake and cGMP levels in rat brain","volume":"28","author":"Taskiran","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib268","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13121441","article-title":"The neural palette of heme: altered heme homeostasis underlies defective neurotransmission, increased oxidative stress, and disease pathogenesis","volume":"13","author":"Soladogun","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2025.e00710_bib269","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","article-title":"Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress","volume":"34","author":"Zhang","year":"2021","journal-title":"J Adv Res"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00710_bib270","doi-asserted-by":"crossref","first-page":"13433","DOI":"10.1074\/jbc.M600246200","article-title":"Dynamics of carbon monoxide binding to cystathionine beta-synthase","volume":"281","author":"Puranik","year":"2006","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib271","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0162-0134(01)00335-X","article-title":"Characterization of NO binding to human cystathionine beta-synthase: possible implications of the effects of CO and NO binding to the human enzyme","volume":"87","author":"Taoka","year":"2001","journal-title":"J Inorg Biochem"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00710_bib272","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/bi9826052","article-title":"Characterization of the heme and pyridoxal phosphate cofactors of human cystathionine beta-synthase reveals nonequivalent active sites","volume":"38","author":"Taoka","year":"1999","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib273","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.22604","article-title":"Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion","volume":"49","author":"Shintani","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib274","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10715762.2020.1862827","article-title":"Gasotransmitter signaling in energy homeostasis and metabolic disorders","volume":"55","author":"Ali","year":"2021","journal-title":"Free Radic Res"},{"key":"10.1016\/j.neurot.2025.e00710_bib275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neurobiolaging.2017.06.017","article-title":"Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment","volume":"58","author":"Song","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurot.2025.e00710_bib276","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.621508","article-title":"Increased plasma heme oxygenase-1 levels in patients with early-stage Parkinson's disease","volume":"13","author":"Sun","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00710_bib277","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbapap.2014.01.002","article-title":"H2S and its role in redox signaling","volume":"1844","author":"Kabil","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00710_bib278","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2009.2919","article-title":"Hydrogen sulfide: from brain to gut","volume":"12","author":"Kimura","year":"2010","journal-title":"Antioxidants Redox Signal"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00710_bib279","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2012.11.001","article-title":"Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells","volume":"48","author":"Kida","year":"2013","journal-title":"Eur J Pharmaceut Sci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib280","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.181.6.4320","article-title":"Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis","volume":"181","author":"Zhang","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib281","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/MN:26:1:013","article-title":"Hydrogen sulfide as a neuromodulator","volume":"26","author":"Kimura","year":"2002","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib282","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2005.04.021","article-title":"The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices","volume":"164","author":"Rutten","year":"2005","journal-title":"Behav Brain Res"},{"issue":"52","key":"10.1016\/j.neurot.2025.e00710_bib283","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.RA120.013716","article-title":"PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression","volume":"295","author":"Corum","year":"2020","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib284","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/FJC.0b013e31820eb7a1","article-title":"Hydrogen sulfide: a novel signaling molecule in the vascular system","volume":"58","author":"Liu","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00710_bib285","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.0800750105","article-title":"Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling","volume":"105","author":"Lerner-Marmarosh","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2025.e00710_bib286","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2015.00119","article-title":"Biliverdin reductase: a target for cancer therapy?","volume":"6","author":"Gibbs","year":"2015","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib287","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.4049\/jimmunol.175.4.2622","article-title":"Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1","volume":"175","author":"Kim","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.neurot.2025.e00710_bib288","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.ph.57.030195.003343","article-title":"Nitric oxide signaling in the central nervous system","volume":"57","author":"Garthwaite","year":"1995","journal-title":"Annu Rev Physiol"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00710_bib289","doi-asserted-by":"crossref","first-page":"11285","DOI":"10.1073\/pnas.88.24.11285","article-title":"Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger","volume":"88","author":"O'Dell","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib290","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.STR.25.3.692","article-title":"Nitric oxide and the cerebral circulation","volume":"25","author":"Faraci","year":"1994","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00710_bib291","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","article-title":"Redox imbalance in Parkinson's disease","volume":"1780","author":"Chinta","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"30","key":"10.1016\/j.neurot.2025.e00710_bib292","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib293","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/ars.2007.1993","article-title":"Reactive nitrogen species: molecular mechanisms and potential significance in health and disease","volume":"11","author":"Mart\u00ednez","year":"2009","journal-title":"Antioxidants Redox Signal"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00710_bib294","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib295","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00710_bib296","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1039\/c2cs15272j","article-title":"Nitric oxide release: part I. Macromolecular scaffolds","volume":"41","author":"Riccio","year":"2012","journal-title":"Chem Soc Rev"},{"issue":"Pt 2","key":"10.1016\/j.neurot.2025.e00710_bib297","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib298","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharep.2016.09.022","article-title":"Contribution of the nitric oxide donor molsidomine and the antiparkinsonian drug l-DOPA to the modulation of the blood pressure in unilaterally 6-OHDA-lesioned rats","volume":"69","author":"Lorenc-Koci","year":"2017","journal-title":"Pharmacol Rep"},{"issue":"2-3","key":"10.1016\/j.neurot.2025.e00710_bib299","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF03033799","article-title":"Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals","volume":"2","author":"Chiueh","year":"2000","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neurot.2025.e00710_bib300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1742-2094-7-83","article-title":"Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"7","author":"L'Episcopo","year":"2010","journal-title":"J Neuroinflammation"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00710_bib301","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1039\/D1BM01077H","article-title":"Fluorescent carbon dots with a high nitric oxide payload for effective antibacterial activity and bacterial imaging","volume":"9","author":"Liu","year":"2021","journal-title":"Biomater Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib302","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acs.bioconjchem.1c00002","article-title":"Theranostic activity of nitric oxide-releasing carbon quantum dots","volume":"32","author":"Jin","year":"2021","journal-title":"Bioconjug Chem"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00710_bib303","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071042","article-title":"PLGA-based nanoparticles for neuroprotective drug delivery in neurodegenerative diseases","volume":"13","author":"Cunha","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neurot.2025.e00710_bib304","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/IJN.S174962","article-title":"Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy","volume":"14","author":"Lee","year":"2019","journal-title":"Int J Nanomed"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib305","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202000377","article-title":"Development and characterization of PLGA-based multistage delivery system for enhanced payload delivery to targeted vascular endothelium","volume":"21","author":"Palma-Chavez","year":"2021","journal-title":"Macromol Biosci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00710_bib306","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/10837450.2020.1740257","article-title":"In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery","volume":"25","author":"Arisoy","year":"2020","journal-title":"Pharmaceut Dev Technol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib307","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4062\/biomolther.2018.009","article-title":"Carbon monoxide ameliorates 6-hydroxydopamine-induced cell death in C6 glioma cells","volume":"26","author":"Moon","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00710_bib308","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1039\/c2cs15317c","article-title":"Developing drug molecules for therapy with carbon monoxide","volume":"41","author":"Rom\u00e3o","year":"2012","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00710_bib309","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.xphs.2015.10.018","article-title":"Toward carbon monoxide-based therapeutics: critical drug delivery and developability issues","volume":"105","author":"Ji","year":"2016","journal-title":"J Pharmacol Sci (Tokyo, Jpn)"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00710_bib310","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tips.2021.02.003","article-title":"Carbon monoxide: from poison to clinical trials","volume":"42","author":"Siracusa","year":"2021","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib311","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40635-020-0292-8","article-title":"Carbon monoxide in intensive care medicine-time to start the therapeutic application?","volume":"8","author":"Goebel","year":"2020","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00710_bib312","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.chest.2017.09.052","article-title":"A phase II clinical trial of low-dose inhaled carbon monoxide in idiopathic pulmonary fibrosis","volume":"153","author":"Rosas","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.neurot.2025.e00710_bib313","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3389\/fimmu.2020.01467","article-title":"Naturally derived heme-oxygenase 1 inducers and their therapeutic application to immune-mediated diseases","volume":"11","author":"Funes","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib314","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0026-895X(24)12118-9","article-title":"Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers","volume":"61","author":"Scapagnini","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"Pt 3","key":"10.1016\/j.neurot.2025.e00710_bib315","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2025.e00710_bib316","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2407-8-197","article-title":"Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice","volume":"8","author":"Nowis","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neurot.2025.e00710_bib317","first-page":"578","article-title":"Nanomotor-based H(2)S donor with mitochondrial targeting function for treatment of Parkinson's disease","volume":"31","author":"Zhao","year":"2024","journal-title":"Bioact Mater"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00710_bib318","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/ml300002m","article-title":"NOSH-aspirin: a novel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory Pharmaceuticals","volume":"3","author":"Kodela","year":"2012","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib319","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bcp.2015.09.014","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications","volume":"98","author":"Kodela","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"6120","key":"10.1016\/j.neurot.2025.e00710_bib320","article-title":"Evidence for neuromelanin involvement in MPTP-induced neurotoxicity","volume":"327","author":"Rj","year":"1987","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00710_bib321","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00005072-199804000-00006","article-title":"Protein nitration in Parkinson's disease","volume":"57","author":"Good","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurot.2025.e00710_bib322","series-title":"Neuroprotection of low dose carbon monoxide in Parkinson's disease models commensurate with the reduced risk of Parkinson's among smokers","author":"Kn","year":"2024"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:20:23Z","timestamp":1772774423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925001886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":322,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925001886"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00710","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00710"}}